Literature DB >> 3355376

Acid-labile human interferon alpha production by peripheral blood mononuclear cells stimulated by HIV-infected cells.

M R Capobianchi1, F De Marco, P Di Marco, F Dianzani.   

Abstract

We compared the properties of interferon (IFN) induced in peripheral blood mononuclear cells (PBMC) by free infectious HIV to that induced by HIV-infected cells fixed with glutaraldehyde. While the IFN induced by HIV was a conventional IFN alpha, the IFN induced by HIV-infected cells, although sharing with IFN alpha both antigenic properties and molecular weight, was strongly inactivated by treatment at pH lower than 4. The ability to induce acid-labile IFN alpha was exerted both by the chronically-infected cell line H9/HIV and by normal PBMC infected in vitro with HIV, while infection of inducers cells with viruses other than HIV made these cells capable of inducing only acid-stable IFN alpha. The cell involved in the production of this type of IFN seems to be B-lymphocyte. Because the presence of acid-labile IFN alpha in the serum of AIDS patients has been described, we suggest that this unusual IFN derives from interaction between circulating B-lymphocytes and the HIV-infected cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355376     DOI: 10.1007/bf01311019

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  21 in total

1.  Role of interferon in AIDS.

Authors:  O T Preble; A H Rook; G V Quinnan; J Vilcek; R M Friedman; R Steis; E P Gelmann; J A Sonnabend
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

2.  Virus yield-reduction assay for interferon by titration of Sindbis virus hemagglutinin.

Authors:  G J Stanton; M P Langford; F Dianzani
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

3.  Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester.

Authors:  P R Clapham; R A Weiss; A G Dalgleish; M Exley; D Whitby; N Hogg
Journal:  Virology       Date:  1987-05       Impact factor: 3.616

4.  Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon.

Authors:  O T Preble; R J Black; R M Friedman; J H Klippel; J Vilcek
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

5.  Fusion as a mediator of cytolysis in mixtures of uninfected CD4+ lymphocytes and cells infected by human immunodeficiency virus.

Authors:  B Yoffe; D E Lewis; B L Petrie; C A Noonan; J L Melnick; F B Hollinger
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

Review 6.  Human T-lymphotropic retroviruses.

Authors:  F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

7.  Human T-cell leukemia/lymphoma virus I and/or Epstein-Barr virus-infected B-cell lines spontaneously produce acid-labile alpha-interferon.

Authors:  D T Boumpas; J J Hooks; M Popovic; G C Tsokos; D L Mann
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

8.  Serum interferon and clinical manifestations of infection with human T-lymphotropic virus type III.

Authors:  J Abb
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

View more
  13 in total

Review 1.  HIV-1 immunopathogenesis in humanized mouse models.

Authors:  Liguo Zhang; Lishan Su
Journal:  Cell Mol Immunol       Date:  2012-04-16       Impact factor: 11.530

2.  Spontaneous release of interferon as a predictor of clinical evolution in HIV-positive subjects.

Authors:  A Biglino; A Surbone; F Lipani; N Cappello; B Forno; A M Pollono; M Busso; A Pugliese
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

3.  Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

Authors:  M R Capobianchi; S Fais; F Mercuri; M Boirivant; F Dianzani; F Pallone
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

4.  Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus.

Authors:  G Rappocciolo; J F Toso; D J Torpey; P Gupta; C R Rinaldo
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

Review 5.  Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.

Authors:  LiGuo Zhang; Eric Meissner; JianZhu Chen; LiShan Su
Journal:  Sci China Life Sci       Date:  2010-03-07       Impact factor: 6.038

6.  Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures.

Authors:  J Szebeni; C Dieffenbach; S M Wahl; C N Venkateshan; A Yeh; M Popovic; S Gartner; L M Wahl; M Peterfy; R M Friedman
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

7.  Absence of circulating interferon in patients with inflammatory bowel disease. Suggestion against an autoimmune etiology.

Authors:  M R Capobianchi; S Fais; M C Di Paolo; D Agostini; P Paoluzi; F Pallone; F Dianzani
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

8.  Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection.

Authors:  J Ferbas; J Navratil; A Logar; C Rinaldo
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

9.  Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.

Authors:  S Fais; M R Capobianchi; F Pallone; P Di Marco; M Boirivant; F Dianzani; A Torsoli
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

10.  Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.

Authors:  Jihed Chehimi; Emmanouil Papasavvas; Costin Tomescu; Bethsebah Gekonge; Shaheed Abdulhaqq; Andrea Raymond; Aidan Hancock; Kavita Vinekar; Craig Carty; Griffin Reynolds; Maxwell Pistilli; Karam Mounzer; Jay Kostman; Luis J Montaner
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.